Background: The therapeutic role of pelvic lymph-node dissection (PLND) for prostate
cancer (PCa) is still unclear. The aim of this study was to assess the impact of the number of …

Study Type–Therapy (case series) Level of Evidence 4 What's known on the subject? and
What does the study add? Pelvic lymph‐node dissection during radical prostatectomy for …

OBJECTIVES: To compare the long-term differences in actuarial biochemical relapse-free
survival rates from a contemporary series of patients who underwent radical prostatectomy …

Objectives. To detect the short-term differences in biochemical relapse-free rates between
patients with and without pelvic lymph node dissection (PLND). Recently, a trend has begun …

Abstract Context Prostate cancer (PCa) patients with isolated clinical lymph node (LN)
relapse, limited to the regional and/or retroperitoneal LNs, may represent a distinct group of …

BACKGROUND: Controversy exists regarding the extent of pelvic lymph node dissection
(PLND) in radical prostatectomy (RP) for prostate cancer. Impact of the extent of PLND may …

Background While the diagnostic value of pelvic lymph node dissection (PLND) during
radical prostatectomy (RP) is undisputed, its therapeutic benefit remains a matter of debate …

Background: The therapeutic effect of pelvic lymph node dissection (PLND) during radical
prostatectomy (RP) due to prostate cancer (PCa) is still under debate. We aimed at …

Background Performing an extended pelvic lymph node dissection (PLND) on all men with
intermediate-and high-risk prostate cancer at the time of a radical prostatectomy (RP) …

OBJECTIVE We tested relationship between pelvic lymph node dissection (PLND) status at
the time of radical prostatectomy (RP) and survival in prostate cancer (PCa) patients …